ADAP
Adaptimmune Therapeutics PLC
Price:
0.28
USD
Volume:
328,164
United Kingdom | Biotechnology
ADAP Current Ratio
As of 2025-05-22, the Current Ratio of Adaptimmune Therapeutics PLC (ADAP) is 2.92.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
ADAP Current Ratio - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 2.92 |
| 2023-12-31 | 2.85 |
| 2022-12-31 | 3.96 |
| 2021-12-31 | 6.65 |
| 2020-12-31 | 10.18 |
| 2019-12-31 | 3.51 |
| 2018-12-31 | 9.47 |
| 2017-12-31 | 3.1 |
| 2016-12-31 | 4.93 |
| 2015-06-30 | 11.04 |
ADAP Current Ratio - Peers Comparison